검색어 : 통합검색[Anderson Gillian]
총 494건 중 494건 출력
, 50/50 페이지
-
491
- Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint
- Boughey, Judy C.; Alvarado, Michael D.; Lancaster, Rachael B.; Fraser Symmans, W.; Mukhtar, Rita; Wong, Jasmine M.; Ewing, Cheryl A.; Potter, David A.; Tuttle, Todd M.; Hieken, Tina J.; Carter, Jodi M.; Jakub, James W.; Kaplan, Henry G.; Buchanan, Claire L.; Jaskowiak, Nora T.; Sattar, Husain A.; Mueller, Jeffrey; Nanda, Rita; Isaacs, Claudine J.; Pohlmann, Paula R.; Lynce, Filipa; Tousimis, Eleni A.; Zeck, Jay C.; Lee, M. Catherine; Lang, Julie E.; Mhawech-Fauceglia, Paulette; Rao, Roshni; Taback, Bret; Godellas, Constantine; Chen, Margaret; Kalinsky, Kevin M.; Hibshoosh, Hanina; Killelea, Brigid; Sanft, Tara; Hirst, Gillian L.; Asare, Smita; Matthews, Jeffrey B.; Perlmutter, Jane; Esserman, Laura J.; Department of Surgery, Mayo Clinic, Rochester, MN USA; UCSF Heller Diller Family Comprehensive Cancer Center, San Francisco, CA USA; Department of Surgery, University of Alabama at Birmingham, Birmingham, AL USA; Department of Pathology, MD Anderson Cancer Center, Houston, TX USA; UCSF Heller Diller Family Comprehensive Cancer Center, San Francisco, CA USA; UCSF Heller Diller Family Comprehensive Cancer Center, San Francisco, CA USA; UCSF Heller Diller Family Comprehensive Cancer Center, San Francisco, CA USA; Department of Medicine, University of Minnesota, Minneapolis, MN USA; Department of Surgery, University of Minnesota, Minneapolis, MN USA; Department of Surgery, Mayo Clinic, Rochester, MN USA; Department of Pathology, Mayo Clinic, Rochester, MN USA; Department of Surgery, Mayo Clinic, Rochester, MN USA; Swedish, Swedish Cancer Institute, Seattle, WA USA; Swedish, Swedish Cancer Institute, Seattle, WA USA; Department of Surgery, University of Chicago, Chicago, IL US; (NPJ breast cancer, v.4, 2018, pp.26)
-
492
- Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer
- Lang, Julie E.; Forero-Torres, Andres; Yee, Douglas; Yau, Christina; Wolf, Denise; Park, John; Parker, Barbara A.; Chien, A. Jo; Wallace, Anne M.; Murthy, Rashmi; Albain, Kathy S.; Ellis, Erin D.; Beckwith, Heather; Haley, Barbara B.; Elias, Anthony D.; Boughey, Judy C.; Yung, Rachel L.; Isaacs, Claudine; Clark, Amy S.; Han, Hyo S.; Nanda, Rita; Khan, Qamar J.; Edmiston, Kristen K.; Stringer-Reasor, Erica; Price, Elissa; Joe, Bonnie; Liu, Minetta C.; Brown-Swigart, Lamorna; Petricoin, Emanuel F.; Wulfkuhle, Julia D.; Buxton, Meredith; Clennell, Julia L.; Sanil, Ashish; Berry, Scott; Asare, Smita M.; Wilson, Amy; Hirst, Gillian L.; Singhrao, Ruby; Asare, Adam L.; Matthews, Jeffrey B.; Melisko, Michelle; Perlmutter, Jane; Rugo, Hope S.; Symmans, W. Fraser; van ‘t Veer, Laura J.; Hylton, Nola M.; DeMichele, Angela M.; Berry, Donald A.; Esserman, Laura J.; University of Southern California, Los Angeles, USA; University of Alabama at Birmingham, Birmingham, USA; University of Minnesota, Minneapolis, USA; University of California San Francisco, San Francisco, USA; University of California San Francisco, San Francisco, USA; University of California San Francisco, San Francisco, USA; University of California San Diego, San Diego, USA; University of California San Francisco, San Francisco, USA; University of California San Francisco, San Francisco, USA; University of Texas MD Anderson Cancer Center, Houston, USA; Loyola University Chicago Stritch School of Medicine, Maywood, USA; Swedish Cancer Institute, Seattle, USA; University of Minnesota, Minneapolis, USA; University of Texas Southwestern, Dallas, USA; University of Colorado, Boulder, USA; Mayo Clinic Rochester, Rochester, USA; University of Washington, Seattle, USA; University of Georgetown, Washington, DC, USA; University of Pennsylvania, Philadelphia, USA; Moffitt C; (NPJ breast cancer, v.8, 2022, pp.128)
-
493
- Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial
-
Pusztai, Lajos;
Yau, Christina;
Wolf, Denise M.;
Han, Hyo S.;
Du, Lili;
Wallace, Anne M.;
String-Reasor, Erica;
Boughey, Judy C.;
Chien, A. Jo;
Elias, Anthony D.;
Beckwith, Heather;
Nanda, Rita;
Albain, Kathy S.;
Clark, Amy S.;
Kemmer, Kathleen;
Kalinsky, Kevin;
Isaacs, Claudine;
Thomas, Alexandra;
Shatsky, Rebecca;
Helsten, Theresa L.;
Forero-Torres, Andres;
Liu, Minetta C.;
Brown-Swigart, Lamorna;
Petricoin, Emmanuel F.;
Wulfkuhle, Julia D.;
Asare, Smita M.;
Wilson, Amy;
Singhrao, Ruby;
Sit, Laura;
Hirst, Gillian L.;
Berry, Scott;
Sanil, Ashish;
Asare, Adam L.;
Matthews, Jeffrey B.;
Perlmutter, Jane;
Melisko, Michelle;
Rugo, Hope S.;
Schwab, Richard B.;
Symmans, W. Fraser;
Yee, Doug;
van’t Veer, Laura J.;
Hylton, Nola M.;
DeMichele, Angela M.;
Berry, Donald A.;
Esserman, Laura J.;
Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine;
Helen Diller Family Comprehensive Cancer Center, University of California;
Department of Laboratory Medicine, University of California;
Medical Oncology, Moffitt Cancer Center;
Department of Pathology, University of Texas MD Anderson Cancer Center;
Comprehensive Breast Health Center, University of California San Diego;
Department of Hematology & Oncology, University of Alabama at Birmingham;
Department of Surgery, Mayo Clinic;
Helen Diller Family Comprehensive Cancer Center, University of California;
Department of Internal Medicine, University of Colorado;
Masonic Cancer Center, University of Minnesota;
Department of Medicine, University of Chicago
; (Cancer cell, v.39, 2021, pp.989-998.e5)
-
494
- Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2 <sup>+</sup> breast cancer in the adaptively randomized I-SPY2 trial
- Clark, Amy S.; Yau, Christina; Wolf, Denise M.; Petricoin, Emanuel F.; van ‘t Veer, Laura J.; Yee, Douglas; Moulder, Stacy L.; Wallace, Anne M.; Chien, A. Jo; Isaacs, Claudine; Boughey, Judy C.; Albain, Kathy S.; Kemmer, Kathleen; Haley, Barbara B.; Han, Hyo S.; Forero-Torres, Andres; Elias, Anthony; Lang, Julie E.; Ellis, Erin D.; Yung, Rachel; Tripathy, Debu; Nanda, Rita; Wulfkuhle, Julia D.; Brown-Swigart, Lamorna; Gallagher, Rosa I.; Helsten, Teresa; Roesch, Erin; Ewing, Cheryl A.; Alvarado, Michael; Crane, Erin P.; Buxton, Meredith; Clennell, Julia L.; Paoloni, Melissa; Asare, Smita M.; Wilson, Amy; Hirst, Gillian L.; Singhrao, Ruby; Steeg, Katherine; Asare, Adam; Matthews, Jeffrey B.; Berry, Scott; Sanil, Ashish; Melisko, Michelle; Perlmutter, Jane; Rugo, Hope S.; Schwab, Richard B.; Symmans, W. Fraser; Hylton, Nola M.; Berry, Donald A.; Esserman, Laura J.; DeMichele, Angela M.; University of Pennsylvania, Philadelphia, PA USA; University of California San Francisco, San Francisco, CA USA; University of California San Francisco, San Francisco, CA USA; George Mason University, Fairfax, VA USA; University of California San Francisco, San Francisco, CA USA; University of Minnesota, Minneapolis, MN USA; MD Anderson Cancer Center, Houston, TX USA; University of California San Diego, San Diego, CA USA; University of California San Francisco, San Francisco, CA USA; Georgetown University, Washington, DC USA; Mayo Clinic, Rochester, MN USA; Loyola University, Chicago, IL USA; Oregon Health & Science University, Portland, OR USA; University of Texas Southwestern, Dallas, TX USA; Moffitt Cancer Center, Tampa, FL USA; University of Alabama Birmingham, Birmingham, AL USA; University of Colorado Denver, Aurora, CO USA; University of Southern California, Los Angeles, CA USA; Swedish Cancer Institute, Seattle, WA USA; University of Washington, Seattle, WA U; (Nature communications, v.12, 2021, pp.6428)
QUICK MENU
